Last Updated: May 10, 2026

List of Excipients in API benzonatate 100 mg

✉ Email this page to a colleague

« Back to Dashboard

Excipients in ANDA-approved (generic) drugs containing benzonatate 100 mg

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC	Excipient
MARKSANS PHARMA LIMITED	benzonatate 100 mg	25000-002	GELATIN
MARKSANS PHARMA LIMITED	benzonatate 100 mg	25000-002	GLYCERIN
MARKSANS PHARMA LIMITED	benzonatate 100 mg	25000-002	PROPYLENE GLYCOL
MARKSANS PHARMA LIMITED	benzonatate 100 mg	25000-002	SHELLAC
MARKSANS PHARMA LIMITED	benzonatate 100 mg	25000-002	SORBITAN
MARKSANS PHARMA LIMITED	benzonatate 100 mg	25000-002	SORBITOL
MARKSANS PHARMA LIMITED	benzonatate 100 mg	25000-002	TITANIUM DIOXIDE
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for benzonatate 100 mg

Excipient focus: GELATIN

benzonatate 100 mg drug variants containing GELATIN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
MARKSANS PHARMA LIMITED	benzonatate 100 mg	25000-002
>Company	>Ingredient	>NDC

benzonatate 100 mg drug variants not containing GELATIN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: GLYCERIN

benzonatate 100 mg drug variants containing GLYCERIN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
MARKSANS PHARMA LIMITED	benzonatate 100 mg	25000-002
>Company	>Ingredient	>NDC

benzonatate 100 mg drug variants not containing GLYCERIN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: PROPYLENE GLYCOL

benzonatate 100 mg drug variants containing PROPYLENE GLYCOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
MARKSANS PHARMA LIMITED	benzonatate 100 mg	25000-002
>Company	>Ingredient	>NDC

benzonatate 100 mg drug variants not containing PROPYLENE GLYCOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SHELLAC

benzonatate 100 mg drug variants containing SHELLAC

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
MARKSANS PHARMA LIMITED	benzonatate 100 mg	25000-002
>Company	>Ingredient	>NDC

benzonatate 100 mg drug variants not containing SHELLAC

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SORBITAN

benzonatate 100 mg drug variants containing SORBITAN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
MARKSANS PHARMA LIMITED	benzonatate 100 mg	25000-002
>Company	>Ingredient	>NDC

benzonatate 100 mg drug variants not containing SORBITAN

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SORBITOL

benzonatate 100 mg drug variants containing SORBITOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
MARKSANS PHARMA LIMITED	benzonatate 100 mg	25000-002
>Company	>Ingredient	>NDC

benzonatate 100 mg drug variants not containing SORBITOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

benzonatate 100 mg drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
MARKSANS PHARMA LIMITED	benzonatate 100 mg	25000-002
>Company	>Ingredient	>NDC

benzonatate 100 mg drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

benzonatate 100 mg drug variants containing WATER

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
MARKSANS PHARMA LIMITED	benzonatate 100 mg	25000-002
>Company	>Ingredient	>NDC

benzonatate 100 mg drug variants not containing WATER

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.